Guide d'implémentation de l'analyse pharmaceutique
0.1.0-ballot - ci-build FR

Guide d'implémentation de l'analyse pharmaceutique - Downloaded Version 0.1.0-ballot See the Directory of published versions

## Accueil

Official URL: https://hl7.fr/ig/fhir/analyse-pharma/ImplementationGuide/hl7.fhir.fr.analyse-pharma | Version: 0.1.0-ballot
Draft as of 2026-05-29 | Computable Name: APH

### Introduction

> Attention ! Cet Implementation Guide n'est pas la version courante. La version courante sera accessible via l'URL canonique (https://hl7.fr/ig/fhir/medication) lorsque celui-ci sera publié.

Ce guide d’implémentation (IG) a pour vocation à spécifier les flux d’information autour de l’analyse pharmaceutique pour un patient dans un contexte hospitalier dans un premier temps.

1. L’analyse pharmaceutique

Ce domaine est pris en charge par le GT Pharmacie d’HL7 France au sein de l’association Interop’Santé. L’historique des versions et des travaux est détaillé dans la page de suivi des travaux.

Cet IG est en développement continu. Certaines sections n’ont pas encore été complètement développées dans cette version. Ces sections sont néanmoins identifiées pour référence.

L’IG intègre également une partie indiquant comment passer de flux PN13 à des ressources FHIR et inversement.

#### Dépendances

IG | Package | FHIR | Comment
--- | --- | --- | ---
Guide d'implémentation de l'analyse pharmaceutique | hl7.fhir.fr.analyse-pharma#0.1.0-ballot | R4 |
HL7 Terminology (THO) | hl7.terminology.r4#7.1.0 | R4 | Automatically added as a dependency - all IGs depend on HL7 Terminology
FHIR Extensions Pack | hl7.fhir.uv.extensions.r4#5.2.0 | R4 |
FHIR Extensions Pack | hl7.fhir.uv.extensions.r4#5.3.0 | R4 | Automatically added as a dependency - all IGs depend on the HL7 Extension Pack
Guide d'implémentation Fr Core | hl7.fhir.fr.core#2.1.0 | R4 |
HL7 Terminology (THO) | hl7.terminology.r4#6.0.2 | R4 |
FHIR Extensions Pack | hl7.fhir.uv.extensions.r4#5.1.0 | R4 |
Nomenclatures des objets de santé (NOS) | ans.fr.nos#1.3.0 | R4 |
Extensions for Using Data Elements from FHIR R5 in FHIR R4 | hl7.fhir.uv.xver-r5.r4#0.1.0 | R4 |
Guide d'implémentation de la ePrescription | ans.fhir.fr.eprescription#1.1.0-ballot | R4 |
FHIR Tooling Extensions IG | hl7.fhir.uv.tools.r4#1.1.2 | R4 | for example references

Package hl7.fhir.uv.extensions.r4#5.2.0 This IG defines the global extensions - the ones defined for everyone. These extensions are always in scope wherever FHIR is being used (built Mon, Feb 10, 2025 21:45+1100+11:00)

Package hl7.fhir.uv.extensions.r4#5.3.0 This IG defines the global extensions - the ones defined for everyone. These extensions are always in scope wherever FHIR is being used (built Sat, May 16, 2026 18:32+1000+10:00)

Package hl7.fhir.uv.extensions.r4#5.1.0 This IG defines the global extensions - the ones defined for everyone. These extensions are always in scope wherever FHIR is being used (built Sat, Apr 27, 2024 18:39+1000+10:00)

Package ans.fr.nos#1.3.0 Les nomenclatures des objets de Sante (built Thu, Aug 29, 2024 14:54+0000+00:00)

Package hl7.fhir.uv.xver-r5.r4#0.1.0 Extensions for Using Data Elements from FHIR R5 in FHIR R4 (built Fri, Mar 20, 2026 15:40+1100+11:00)

Package hl7.fhir.uv.tools.r4#1.1.2 This IG defines the extensions that the tools use internally. Some of these extensions are content that are being evaluated for elevation into the main spec, and others are tooling concerns (built Tue, Mar 24, 2026 11:13+1100+11:00)

#### Propriété intellectuelle

Certaines ressources sémantiques de ce guide sont protégées par des droits de propriété intellectuelle couverte par les déclarations ci-dessous. L’utilisation de ces ressources est soumise à l’acceptation et au respect des conditions précisées dans la licence d’utilisation de chacune d’entre elle.

- ISO maintains the copyright on the country codes, and controls its use carefully. For further details see the ISO 3166 web page: https://www.iso.org/iso-3166-country-codes.html
  Show Usage
  - ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code: APH, FRInpatientPharmaceuticalAnalysisResultProfile... Show 13 more, FRInpatientPharmaceuticalInterventionSuggestionProfile, FrAnalysePharmaceutiqueLogical, FrPN13FHIRPharmaceuticalAnalysisInterventionSansPropositionConceptMap, FrPN13FHIRPharmaceuticalAnalysisValidationConceptMap, FrPharmaceuticalAnalysisPerformerTypeValueSet, FrPharmaceuticalAnalysisResultCode, FrPharmaceuticalAnalysisResultCodeValueSet, FrPharmaceuticalInterventionDevenirCode, FrPharmaceuticalInterventionDevenirCodeValueSet, FrPharmaceuticalInterventionProblemCode, FrPharmaceuticalInterventionProblemCodeValueSet, FrPharmaceuticalInterventionTypeCode and FrPharmaceuticalInterventionTypeCodeValueSet
- The UCUM codes, UCUM table (regardless of format), and UCUM Specification are copyright 1999-2009, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM) Organization. All rights reserved. https://ucum.org/trac/wiki/TermsOfUse
  Show Usage
  - Unified Code for Units of Measure (UCUM): Bundle/MultiLine-Presc-Sucralfate-Paracetamol, Medication/InLine-DOLIPRANE... Show 14 more, Medication/InLine-med-EFFERALGAN, MedicationRequest/InLine-Analyse-Presc-CETAFEN-INJ, MedicationRequest/InLine-Analyse-Presc-NEFOPAM, MedicationRequest/InLine-Analyse-Presc-Paracetamol, MedicationRequest/InLine-Analyse-Presc-Paracetamol-Si-Douleur, MedicationRequest/InLine-Inter-Arret-Paracetamol-Si-Douleur, MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Intervention-Proposition, MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Intervention-Substitution, MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Presc-Paracetamol, MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Validation-Proposition, MedicationRequest/InLine-presc-Paracetamol1, MedicationRequest/InLine-presc-Paracetamol2, Observation/InLine-Observation-poids-Avion and Observation/InLine-observation-taille-Avion
- This material contains content from LOINC. LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc.
  Show Usage
  - LOINC: Observation/InLine-Observation-poids-Avion and Observation/InLine-observation-taille-Avion
- This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org.
  Show Usage
  - SNOMED Clinical Terms&reg; (SNOMED CT&reg;): MedicationRequest/InLine-Analyse-Presc-Paracetamol-Si-Douleur, MedicationRequest/InLine-Inter-Arret-Paracetamol-Si-Douleur and MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Presc-Paracetamol
- Unless otherwise indicated, reproduction of material posted on Council of Europe websites, and reproduction of photographs for which the Council of Europe holds copyright – see legal notice \“photo credits\” – is authorised for private use and for informational and educational uses relating to the Council of Europe’s work. This authorisation is subject to the condition that the source be indicated and no charge made for reproduction. Persons wishing to make some other use than those specified above, including commercial use, of information and text posted on these sites are asked to apply for prior written authorisation to the Council of Europe, Directorate of Communication.
  Show Usage
  - EDQM Standard Terms: Bundle/MultiLine-Presc-METFORMINE-GLICLAZIDE, Bundle/MultiLine-Presc-METHOTREXATE-LEDERFOLINE... Show 37 more, Bundle/MultiLine-Presc-Sucralfate-Paracetamol, Medication/InLine-DOLIPRANE, Medication/InLine-med-EFFERALGAN, MedicationRequest/InLine-Analyse-Presc-BINOCRIT, MedicationRequest/InLine-Analyse-Presc-CALCIDOSE, MedicationRequest/InLine-Analyse-Presc-CELLUVISC, MedicationRequest/InLine-Analyse-Presc-CETAFEN-CPR, MedicationRequest/InLine-Analyse-Presc-CETAFEN-INJ, MedicationRequest/InLine-Analyse-Presc-COTAREG, MedicationRequest/InLine-Analyse-Presc-DOSTINEX, MedicationRequest/InLine-Analyse-Presc-Diazepam, MedicationRequest/InLine-Analyse-Presc-ELIQUIS-25, MedicationRequest/InLine-Analyse-Presc-ELIQUIS-50, MedicationRequest/InLine-Analyse-Presc-ESIDREX, MedicationRequest/InLine-Analyse-Presc-ESOMEPRAZOLE, MedicationRequest/InLine-Analyse-Presc-EZETIMIBE, MedicationRequest/InLine-Analyse-Presc-INEGY, MedicationRequest/InLine-Analyse-Presc-INNOHEP, MedicationRequest/InLine-Analyse-Presc-LACRIFLUID, MedicationRequest/InLine-Analyse-Presc-LANSOPRAZOLE, MedicationRequest/InLine-Analyse-Presc-LEVOTHYROX, MedicationRequest/InLine-Analyse-Presc-LOXAPAC, MedicationRequest/InLine-Analyse-Presc-MACROGOL, MedicationRequest/InLine-Analyse-Presc-METFORMINE, MedicationRequest/InLine-Analyse-Presc-Morphine, MedicationRequest/InLine-Analyse-Presc-NEFOPAM, MedicationRequest/InLine-Analyse-Presc-Paracetamol, MedicationRequest/InLine-Analyse-Presc-SIMVASTATINE, MedicationRequest/InLine-Analyse-Presc-TAREG, MedicationRequest/InLine-Presc-EFFERALGAN, MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Intervention-Proposition, MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Intervention-Substitution, MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Presc-Paracetamol, MedicationRequest/InLine-Trad-PN13-FHIR-Analyse-Validation-Proposition, MedicationRequest/InLine-presc-EFFERALGAN2, MedicationRequest/InLine-presc-Paracetamol1 and MedicationRequest/InLine-presc-Paracetamol2